Energenesis Biomedical CO.,LTD. (TWSE: 6657)
Health Care · Biotechnology · TW
NT$32.90
+0.30% today · -36.4% 1Y
Energenesis Biomedical CO.,LTD. (TWSE: 6657) operates in the Biotechnology industry within the Health Care sector. The company is valued at $90.79M and employs 35 people.
Over the last twelve months the share price has lost 36.4%, trading between 28.35 and 59.70.
Tweenvest scores Energenesis Biomedical CO.,LTD. across four factors: quality 48/100, value 33/100, growth 20/100. Its strongest factor is quality.
6657 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $90.79M
- Revenue (TTM)
- $240.14K
- P/E
- —
- EPS
- -3.38
- Dividend yield
- —
- Beta (5Y)
- 0.40
- 52-week high
- NT$59.70
- 52-week low
- NT$28.35
- Avg volume (3M)
- —
- Shares outstanding
- 87.91M
- Employees
- 35
- Next earnings
- —
About Energenesis Biomedical CO.,LTD.
Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.
- ISIN
- TW0006657000
- Founded
- 2012
- Listed since
- Jun 1, 2023
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Atara Biotherapeutics, Inc.NasdaqGS: ATRA | $92.65M | $9.23 | -1.49% |
| Devyser Diagnostics AB (publ)OM: DVYSR | $92.23M | Skr51.10 | -6.75% |
| Cellectis S.A.ENXTPA: ALCLS | $91.67M | €1.13 | -8.31% |
| Medivir AB (publ)OM: MVIR | $91.09M | Skr1.46 | -5.56% |
| Rallybio CorporationNasdaqCM: RLYB | $90.70M | $16.99 | -0.53% |
| CanBas Co., Ltd.TSE: 4575 | $89.55M | ¥739.00 | +0.82% |
| Equillium, Inc.NasdaqCM: EQ | $89.41M | $1.44 | +2.13% |
| Bonraybio Co., Ltd.TWSE: 6955 | $89.17M | NT$93.50 | -0.74% |
Figures last refreshed Oct 4, 2026.